NASDAQ | ETF
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies.
The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.52% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 7.83% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.91% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.97% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.85% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.62% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.43% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.20% |
| BDX | Becton Dickinson and Company | Healthcare | Medical Instruments & Supplies | 3.09% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.64% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.00% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 1.74% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.64% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 1.62% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.49% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.46% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 1.37% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 1.33% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.31% |